Mucomyst and Rash maculo-papular - a phase IV clinical study of FDA data

Summary:

Rash maculo-papular is reported as a side effect among people who take Mucomyst (acetylcysteine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Zocor, and have Tracheobronchitis.

The phase IV clinical study analyzes which people have Rash maculo-papular when taking Mucomyst. It is created by eHealthMe based on reports of 1,823 people who have side effects when taking Mucomyst from the FDA, and is updated regularly.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

What is Rash maculo-papular?

Rash maculo-papular (red area on the skin that is covered with small confluent bumps) is found to be associated with 1,243 drugs and 1,534 conditions by eHealthMe. Check the latest studies of Rash maculo-papular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,823 people reported to have side effects when taking Mucomyst.
Among them, 14 people (0.77%) have Rash maculo-papular.

Could Mucomyst cause Rash maculo-papular?

Among these 14 people:

How long have people been on Mucomyst when they have Rash maculo-papular? *

What is the gender of people who have Rash maculo-papular when taking Mucomyst? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Rash maculo-papular when taking Mucomyst? *

What are other drugs people take besides Mucomyst? *

What are other side effects people have besides Rash maculo-papular? *

Fever: 8 people, 57.14%
Itching: 4 people, 28.57%
Rashes (redness): 4 people, 28.57%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 3 people, 21.43%
Oedema Peripheral (superficial swelling): 3 people, 21.43%
Laryngeal Oedema (swelling of larynx): 2 people, 14.29%
Stable Angina (a constant chest pain): 2 people, 14.29%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 14.29%
Lung Cancer Stage Unspecified (Exc Metastatic Tumors To Lung): 2 people, 14.29%
Purpura (purplish discoloration of the skin): 2 people, 14.29%

What are the existing conditions these people have? *

Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract): 2 people, 14.29%
Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate): 1 person, 7.14%
Respiratory Disorder (respiratory disease): 1 person, 7.14%
Hypokalemia (low potassium): 1 person, 7.14%
Heart Disease: 1 person, 7.14%
Cystic Fibrosis (disease of the secretary glands): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Mucomyst and have Rash maculo-papular?

- Check whether Rash maculo-papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mucomyst:

Mucomyst (1,835 reports)

Browse all side effects of Mucomyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash maculo-papular:

Rash maculo-papular (1,243 drugs)

Browse all the conditions that are associated with Rash maculo-papular:

Rash maculo-papular (1,534 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetylcysteine (the active ingredients of Mucomyst) and Mucomyst (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.